Shankheshwar Impex Private Limited
Retail trading of pharmaceutical and surgical products, including antibiotics and medicine.
2012 | Indore, Madhya Pradesh (India) | Active
Shankheshwar Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.90 M
- Revenue Growth 3.37%
- Profit Growth -23.63%
- Ebitda -29.01%
- Net Worth -70.79%
- Total Assets 452.26%
About Shankheshwar Impex
Shankheshwar Impex Private Limited (SIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 September 2012 and has a history of 12 years and five months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.90 M.
Kanchan Sharma, Mohit Jain, and Kamal Sharma serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397MP2012PTC029213
- Company No.
029213
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Pharma
Who are the key members and board of directors at Shankheshwar Impex?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanchan Sharma  | Director | 13-Sep-2012 | Current |
| Mohit Jain | Director | 13-Sep-2012 | Current |
| Kamal Sharma | Director | 12-Jan-2016 | Current |
Financial Performance of Shankheshwar Impex.
Shankheshwar Impex Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.37% increase. The company also saw a substantial fall in profitability, with a 23.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 70.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shankheshwar Impex?
In 2020, Shankheshwar Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹4.90 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.49 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2016 | Hdfc Bank Limited | ₹4.90 M | Open |
How Many Employees Work at Shankheshwar Impex?
Unlock and access historical data on people associated with Shankheshwar Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shankheshwar Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shankheshwar Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.